X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20869) 20869
Book Chapter (78) 78
Newspaper Article (17) 17
Newsletter (14) 14
Book / eBook (12) 12
Magazine Article (8) 8
Conference Proceeding (5) 5
Publication (3) 3
Reference (2) 2
Web Resource (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11754) 11754
animals (8196) 8196
male (6209) 6209
female (5991) 5991
proteins (4114) 4114
biochemistry & molecular biology (3220) 3220
middle aged (3204) 3204
serum (3166) 3166
mice (3027) 3027
adult (2991) 2991
albumin (2655) 2655
analysis (2601) 2601
serum albumin (2436) 2436
aged (2296) 2296
research article (2175) 2175
medicine (2150) 2150
multidisciplinary sciences (2106) 2106
research (2031) 2031
rats (2011) 2011
cell biology (1939) 1939
expression (1866) 1866
serum albumin - metabolism (1736) 1736
science (1672) 1672
cattle (1569) 1569
protein binding (1542) 1542
health aspects (1537) 1537
risk factors (1468) 1468
gene expression (1458) 1458
physiological aspects (1433) 1433
immunology (1430) 1430
biomarkers (1422) 1422
inflammation (1394) 1394
cancer (1355) 1355
oncology (1236) 1236
protein (1216) 1216
serum albumin - genetics (1204) 1204
biochemistry (1196) 1196
studies (1179) 1179
binding (1175) 1175
cells, cultured (1157) 1157
metabolism (1154) 1154
endocrinology & metabolism (1137) 1137
liver (1136) 1136
pharmacology & pharmacy (1133) 1133
patients (1126) 1126
disease (1089) 1089
biotechnology & applied microbiology (1055) 1055
oxidative stress (1050) 1050
life sciences (1037) 1037
diabetes (1021) 1021
molecular sequence data (1013) 1013
diagnosis (1008) 1008
fluorescence (1008) 1008
medicine, research & experimental (996) 996
amino acid sequence (987) 987
physiology (976) 976
enzymes (960) 960
enzyme-linked immunosorbent assay (953) 953
care and treatment (940) 940
mortality (939) 939
binding sites (933) 933
rodents (929) 929
genetic aspects (924) 924
cells (922) 922
dna (920) 920
biomarkers - blood (917) 917
biophysics (914) 914
chemistry (912) 912
biology (905) 905
plasma (901) 901
cell line (882) 882
bovine serum albumin (875) 875
antibodies (858) 858
blood (858) 858
serum-albumin (855) 855
serum albumin - analysis (852) 852
medical research (840) 840
adolescent (837) 837
in-vitro (829) 829
human serum-albumin (819) 819
biology and life sciences (818) 818
serum albumin - chemistry (815) 815
apoptosis (814) 814
prognosis (809) 809
biochemistry, general (801) 801
mass spectrometry (799) 799
medicine and health sciences (792) 792
human serum albumin (789) 789
time factors (780) 780
kinetics (774) 774
aged, 80 and over (757) 757
identification (757) 757
liver - metabolism (739) 739
proteomics (727) 727
biotechnology (722) 722
young adult (717) 717
medicine & public health (716) 716
cytokines (713) 713
serum levels (712) 712
risk (700) 700
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20815) 20815
Japanese (117) 117
French (47) 47
German (47) 47
Chinese (46) 46
Russian (45) 45
Portuguese (25) 25
Italian (18) 18
Norwegian (15) 15
Spanish (13) 13
Dutch (12) 12
Danish (6) 6
Arabic (4) 4
Ukrainian (4) 4
Korean (3) 3
Swedish (3) 3
Croatian (2) 2
Polish (2) 2
Serbian (2) 2
Czech (1) 1
Hungarian (1) 1
Malay (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular aspects of medicine, ISSN 0098-2997, 2012, Volume 33, Issue 3, pp. 209 - 290
Human serum albumin (HSA), the most abundant protein in plasma, is a monomeric multi-domain macromolecule, representing the main determinant of plasma oncotic pressure and the main modulator of fluid distribution between body compartments... 
Ligand binding properties | Human serum albumin | Human serum heme–albumin | Biotechnological applications | Biomedical aspects | Allostery | (Pseudo-)enzymatic properties | Genetic variants | Structure | Recombinant human serum albumin | Chemical modifications | Human serum heme-albumin | FAMILIAL DYSALBUMINEMIC HYPERTHYROXINEMIA | MEDICINE, RESEARCH & EXPERIMENTAL | ESTERASE-LIKE ACTIVITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | CRYSTALLOGRAPHIC ANALYSIS REVEALS | AMINO-ACID SUBSTITUTIONS | HIGH-AFFINITY BINDING | ISCHEMIA-MODIFIED ALBUMIN | PLASMA-PROTEIN-BINDING | PERFORMANCE LIQUID-CHROMATOGRAPHY | HIGH-LEVEL SECRETION | ALPHA-FETOPROTEIN GENES | Recombinant Proteins - metabolism | Recombinant Proteins - therapeutic use | Serum Albumin - therapeutic use | Humans | Serum Albumin - genetics | Recombinant Proteins - chemistry | Recombinant Proteins - genetics | Serum Albumin - chemistry | Serum Albumin - metabolism | Myoglobin | Atomic force microscopy | RNA | Prosthesis | Low density lipoproteins | Phthalocyanins | Postmenopausal women | Thioredoxin | Proteins | Iron compounds | Messenger RNA | Vitamin D | Heme | Thyroxine | Hemoglobin | Blood lipids | Thyroid hormones | Alfacalcidol | Chromosomes | Protein binding | Antigens | Enzymes | Biological products | Liver diseases | Albumin | Calcifediol | Fatty acids | Rheumatoid factor | Implants, Artificial | Rheumatoid arthritis | Ferroalloys | CEA (Oncology)
Journal Article
Journal Article
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2012, Volume 7, Issue 4, p. e35710
.... In this study, we investigated the mechanism underlying the anti-tumor effects of a TIMP-2 fusion protein conjugated with human serum albumin (HSA/TIMP-2... 
APOPTOSIS | ACTIVATION | THERAPY | MATRIX-METALLOPROTEINASE | MULTIDISCIPLINARY SCIENCES | IN-VIVO | ESCHERICHIA-COLI | DOWN-REGULATION | TISSUE INHIBITOR | CELL-PROLIFERATION | CANCER | Human Umbilical Vein Endothelial Cells | Humans | Recombinant Fusion Proteins - therapeutic use | Serum Albumin - genetics | Male | Prostate - metabolism | Tissue Inhibitor of Metalloproteinase-2 - genetics | Neovascularization, Pathologic - pathology | Tissue Inhibitor of Metalloproteinase-2 - therapeutic use | Prostate - pathology | Prostatic Neoplasms - genetics | Angiogenesis Inhibitors - therapeutic use | Prostate - drug effects | Prostate - blood supply | Gene Expression Regulation, Neoplastic - drug effects | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - blood supply | Prostatic Neoplasms - pathology | Angiogenesis Inhibitors - genetics | Rats | Serum Albumin - therapeutic use | Matrix Metalloproteinase 2 - genetics | Animals | Mice, Nude | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Recombinant Fusion Proteins - genetics | Neovascularization, Pathologic - genetics | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Care and treatment | RNA | Growth | Albumin | Research | Tumors | Cancer | Laboratories | Science | Clinical trials | mRNA | Tissue inhibitor of metalloproteinase 2 | Tissues | Vascularization | Anticancer properties | Proteins | Angiogenesis | Reduction | Cell growth | Rodents | Penicillin | Inhibition | Fusion protein | Vascular endothelial growth factor | Human serum albumin | Melanoma | Serum albumin | Metabolism | Gene expression | CD31 antigen | Endothelial cells | Gelatinase A | In vivo methods and tests | Gene therapy | Prostate cancer | Umbilical vein | Apoptosis
Journal Article
1996, ISBN 9780125521109, 455
The first of its kind, All About Albumin summarizes the chemistry, genetics, metabolism, clinical implications, and commercial aspects of albumin... 
Serum albumin
eBook